Integrated sensor engineering and AI-assisted peptide design to target the Zika virus NS2B-NS3 protease
Abstract
Zika virus NS2B-NS3 protease (ZVP) is an essential enzyme for viral replication and a promising antiviral drug target. However, peptide-based inhibitor design remains challenging. Here, we developed an integrated workflow combining a recombinant FRET-based protease sensor with AI-driven peptide inhibitor design. The engineered PEprot ZIKV sensor, containing the ZVP cleavage sequence between two fluorescently labeled domains, enabled quantitative activity assays. PEprot ZIKV showed ~ 5.5-fold higher catalytic efficiency ( k cat / K m = 49 ± 7 × 10 ⁶ M ⁻¹ s − 1 ) and a lower K m (4 nM) than a chemically synthesized substrate (22 nM) bearing the same cleavage sequence, with comparable catalytic turnover. Structural hotspot mapping of 53 ZVP crystal structures and multiple sequence alignment of flaviviral polyprotein motifs guided de novo peptide generation using RFdiffusion and ProteinMPNN. Computational filtering (docking, AlphaFold-3 co-folding, MD simulations and MM/PBSA) prioritized short peptides for testing. Biochemical screening with PEprot ZIKV identified three candidate inhibitors, with peptide 715 showing the strongest activity (IC ₅₀ = 214 µM), followed by 630 and 701. Structure-guided peptide elongation improved 630-derived variants (e.g., 630_03, IC ₅₀ = 224 µM) but reduced potency for 701- and 715-derived sequences. This integrated approach offers a generalizable framework to accelerate the discovery of peptide inhibitors against ZVP and other viral proteases.
Related
- Hybrid plasmonic–photonic multi-Fano resonance refractive index sensor using periodic gold nano-bar assisted microcavity coupling
- Engineering a multifunctional LL37-TP5 hybrid peptide with potent antimicrobial endotoxin-neutralizing and anti-inflammatory properties
- AI-Assisted Nutrition Estimation and Exercise Support for Integrated Lifestyle Management in Patients with Diabetes
- AI-Assisted Triage for Diabetic Retinopathy Integrated into Routine Diabetes Care: A Real-World Diagnostic Accuracy Study of the DAIRET® Algorithm
- From revascularization to multimodal integrated therapy for peripheral arterial disease: immunomodulation, metabolic correction, and tissue engineering
BibTeX
@article{cadillovalverde2026integrated,
title = {{Integrated sensor engineering and AI-assisted peptide design to target the Zika virus NS2B-NS3 protease}},
author = {Alejandro Cadillo-Valverde and Ana Sanchez-Castro and Pohl Milon},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73774-3},
url = {https://www.nature.com/articles/s41598-026-73774-3},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Integrated sensor engineering and AI-assisted peptide design to target the Zika virus NS2B-NS3 protease
AU - Alejandro Cadillo-Valverde
AU - Ana Sanchez-Castro
AU - Pohl Milon
PY - 2026
DA - 2026/10/15
JO - Scientific Reports
DO - 10.1038/s41598-026-73774-3
UR - https://www.nature.com/articles/s41598-026-73774-3
AB - Zika virus NS2B-NS3 protease (ZVP) is an essential enzyme for viral replication and a promising antiviral drug target. However, peptide-based inhibitor design remains challenging. Here, we developed an integrated workflow combining a recombinant FRET-based protease sensor with AI-driven peptide inhibitor design. The engineered PEprot ZIKV sensor, containing the ZVP cleavage sequence between two fluorescently labeled domains, enabled quantitative activity assays. PEprot ZIKV showed ~ 5.5-fold higher catalytic efficiency ( k cat / K m = 49 ± 7 × 10 ⁶ M ⁻¹ s − 1 ) and a lower K m (4 nM) than a chemically synthesized substrate (22 nM) bearing the same cleavage sequence, with comparable catalytic turnover. Structural hotspot mapping of 53 ZVP crystal structures and multiple sequence alignment of flaviviral polyprotein motifs guided de novo peptide generation using RFdiffusion and ProteinMPNN. Computational filtering (docking, AlphaFold-3 co-folding, MD simulations and MM/PBSA) prioritized short peptides for testing. Biochemical screening with PEprot ZIKV identified three candidate inhibitors, with peptide 715 showing the strongest activity (IC ₅₀ = 214 µM), followed by 630 and 701. Structure-guided peptide elongation improved 630-derived variants (e.g., 630_03, IC ₅₀ = 224 µM) but reduced potency for 701- and 715-derived sequences. This integrated approach offers a generalizable framework to accelerate the discovery of peptide inhibitors against ZVP and other viral proteases.
SN - 2045-2322
ER -